3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Lung Carcinoma: new trials by email Literature Review of Lung Carcinoma trials Research Report on Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Canakinumab in High-Risk Former-Smokers Biospecimen Collection, Bronchoscopy, Canakinumab - Cigarette Smoking-Related Carcinoma, Lung Carcinoma | Phase 2 | Completed | Peter Shields | 41 | 2024-03-11 | 2026-07-07 |
| 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Computed Tomography, fluorodeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392 - Lung Carcinoma, Solitary Pulmonary Nodule | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 46 | 2015-06-16 | 2022-10-19 |
| Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers Aspirin, Laboratory Biomarker Analysis, Placebo - Lung Carcinoma, Tobacco Use Disorder | Phase 2 | Completed | National Cancer Institute (NCI) | 54 | 2014-06-01 | 2018-08-29 |
Lung Neoplasms (3) · Cigarette Smoking (1) · Solitary Pulmonary Nodule (1) · Tobacco Use Disorder (1)
Lung Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Behavior (1) · Chemically-Induced Disorders (1) · Mental Disorders (1) · Smoking (1) · Substance-Related Disorders (1) · Tobacco Smoking (1) · Tobacco Use (1)
4-(3-fluoropropyl)glutamic acid (1) · Aspirin (1) · Bronchoscopy (1) · Carbon Monoxide (1) · Fluorodeoxyglucose F18 (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · canakinumab (1)
National Cancer Institute (NCI) (1) · Peter Shields (1) · Vanderbilt-Ingram Cancer Center (1)
United States (3)
Chirayu Shah, MD (1) · Linda Garland (1) · Peter G Shields, MD (1)
N01CN00031 (1), P30CA023074 (1), P30CA068485 (1)